Renovis RNVS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Renovis RNVS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	9/26/2005 4:36:23 AM
	Read Replies (2) of 45

Renovis Announces Pricing of Public Offering of Common Stock 8:00 AM EDT September 23, 2005 Renovis, Inc. (Nasdaq: RNVS) today announced the pricing of its public offering of 4,000,000 shares of common stock at $13.50 per share. All of the shares are being offered by Renovis. The company has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any. The offering is expected to close on September 28, 2005. Goldman, Sachs & Co. is acting as the sole book-running manager of the offering. CIBC World Markets Corp., Piper Jaffray & Co. and SG Cowen & Co., LLC are co-managers of the offering.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next